Search results for "Highlights"
Rivaroxaban associated with increased risk for GI bleeding compared to other DOACs
A study in Iceland of direct oral anticoagulants (DOACs) found a higher risk for overall and major GI bleeding with rivaroxaban than with either apixaban or dabigatran.
https://gastroenterology.acponline.org/archives/2021/10/22/1.htm
22 Oct 2021
Risk and severity of NAFLD differ in men and women
Women have a significantly lower risk of developing nonalcoholic fatty liver disease (NAFLD) but a higher risk of developing advanced fibrosis from NAFLD, according to a systematic review and meta-analysis.
https://gastroenterology.acponline.org/archives/2020/05/22/3.htm
22 May 2020
COVID-19 mRNA vaccines appear effective in patients with cirrhosis
A retrospective cohort study compared outcomes among U.S. veterans with cirrhosis who received at least one dose of an mRNA COVID-19 vaccine with those of a propensity-matched control group of unvaccinated patients at similar risk.
https://gastroenterology.acponline.org/archives/2021/07/23/1.htm
23 Jul 2021
Steroids may not be needed with anti-TNF induction in Crohn's disease
Rates of clinical remission and clinical response were 32.0% and 42.7%, respectively, in Crohn's disease patients receiving therapy with both corticosteroids and anti-tumor necrosis factor (TNF) agents and 35.5% and 46.8% in those receiving only anti-TNF agents, a systematic review and meta-analysis found.
https://gastroenterology.acponline.org/archives/2020/06/26/3.htm
26 Jun 2020
Patients with IBD who catch COVID-19 have high clot risk, study finds
Infection with SARS-CoV-2 was associated with an eightfold increase in the risk of venous thromboembolism among patients with inflammatory bowel disease (IBD), but the risk was mitigated by chronic anticoagulation, according to a retrospective study.
https://gastroenterology.acponline.org/archives/2021/06/25/1.htm
25 Jun 2021
Guidance offered for managing colorectal dysplasia in patients with IBD
Among other best practice advice from the American Gastroenterological Association, precancerous colorectal lesions in patients with inflammatory bowel disease (IBD) should be described as polypoid, nonpolypoid, or invisible using a modified Paris Classification.
https://gastroenterology.acponline.org/archives/2021/09/24/1.htm
24 Sep 2021
Semaglutide showed some benefit in patients with NASH, liver fibrosis
Significantly more patients taking the glucagon-like peptide-1 receptor agonist had resolution of their nonalcoholic steatohepatitis (NASH) than those taking placebo, but rates of liver fibrosis improvement were similar between groups, an industry-funded trial found.
https://gastroenterology.acponline.org/archives/2020/11/20/1.htm
20 Nov 2020
Treatment algorithm updated for chronic HBV
The recommendations address use of newer therapies and are intended to offer guidance on treating chronic hepatitis B virus (HBV) infection while additional antiviral agents are in development.
https://gastroenterology.acponline.org/archives/2021/08/27/1.htm
27 Aug 2021
Drinking coffee may reduce risk of death, disease progression in patients with advanced colorectal cancer, study finds
An editorial noted coffee's unique role in diet, as it is widely consumed as a daily habit, and explained why a potential link between coffee consumption and colorectal cancer is biologically plausible.
https://gastroenterology.acponline.org/archives/2020/09/25/1.htm
25 Sep 2020
Cirrhosis puts COVID-19 patients at higher risk of hospitalization, death
An analysis of U.S. veterans with and without cirrhosis who were tested for SARS-CoV-2 this spring found a 30-day mortality rate of 17.1% in patients with both conditions, compared to 2.3% in those with neither COVID-19 nor cirrhosis.
https://gastroenterology.acponline.org/archives/2020/12/18/1.htm
18 Dec 2020